Geldanamycin
CAS No. 30562-34-6
Geldanamycin ( NSC 122750 )
产品货号. M13974 CAS No. 30562-34-6
Geldanamycin 是一种天然存在的 HSP90 抑制剂,Kd 为 1.2 μM,特异性破坏糖皮质激素受体 (GR)/HSP 关联。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥563 | 有现货 |
|
| 5MG | ¥938 | 有现货 |
|
| 10MG | ¥1549 | 有现货 |
|
| 25MG | ¥2530 | 有现货 |
|
| 50MG | ¥3525 | 有现货 |
|
| 100MG | ¥4797 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1216 | 有现货 |
|
生物学信息
-
产品名称Geldanamycin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Geldanamycin 是一种天然存在的 HSP90 抑制剂,Kd 为 1.2 μM,特异性破坏糖皮质激素受体 (GR)/HSP 关联。
-
产品描述Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.(In Vitro):Geldanamycin significantly delays and reduces viperin expression, indicating that IRF3 is involved in viperin induction in RAW264.7 cells. Geldanamycin (GA), a benzoquinone ansamycin, protected against neuronal injury induced by oxygen-glucose deprivation (OGD)/zVAD treatment in cultured primary neurons. More importantly, Geldanamycin decreases RIP1 protein level in a time and concentration-dependent manner. Geldanamycin also decreases the Hsp90 protein level, which causes instability of RIP1 protein, resulting in decreased RIP1 protein level but not RIP1 mRNA level after Geldanamycin treatment. Geldanamycin (GA) is identified as the first natural product inhibitor of Hsp90 that binds to the N-terminal ATPase domain of Hsp90 to inhibit its chaperone function, and significantly induces tumor cell death via an apoptotic mechanism.
-
体外实验——
-
体内实验——
-
同义词NSC 122750
-
通路Cytoskeleton/Cell Adhesion Molecules
-
靶点HSP
-
受体HSP90| HSP90| p185
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number30562-34-6
-
分子量560.64
-
分子式C29H40N2O9
-
纯度>98% (HPLC)
-
溶解度DMSO:50 mg/mL warmed (89.18 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
-
SMILESNC(O[C@@H](/C(C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC1=C2OC)[C@@H](OC)/C=C\C=C(C)\C(NC(C1=O)=CC2=O)=O)=O
-
化学全称(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Roe SM, et al, J Med Chem, 1999, 42(2), 260-266.
产品手册
关联产品
-
PU-H71 HCl
PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of malignancy. PU-H71 HCL has an inhibitory effect on the protein expression levels of Rad51 and Ku70, which may be associated with the double chain break repair in the homologous recombination pathway and non-homologous end-joining pathway.
-
NSC 145366
NSC 145366 是一种新型变构 Hsp90 CTD(C 末端结构域)抑制剂。
-
KU-32
一种基于新生霉素的新型 Hsp90 C 末端抑制剂和 Hsp70 的有效诱导剂。
021-51111890
购物车()
sales@molnova.cn

